These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8425205)

  • 1. Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.
    Montgomery AM; De Clerck YA; Langley KE; Reisfeld RA; Mueller BM
    Cancer Res; 1993 Feb; 53(3):693-700. PubMed ID: 8425205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
    Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells.
    Borchers AH; Sanders LA; Powell MB; Bowden GT
    Exp Cell Res; 1997 Feb; 231(1):61-5. PubMed ID: 9056412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices.
    Ntayi C; Lorimier S; Berthier-Vergnes O; Hornebeck W; Bernard P
    Exp Cell Res; 2001 Oct; 270(1):110-8. PubMed ID: 11597133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
    Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM; Waghray A
    Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Meade-Tollin LC; Way D; Witte MH
    Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
    Emenaker NJ; Basson MD
    J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
    Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T; Masson R; Basset P; Blasi F; Talarico D
    Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
    Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
    Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C
    J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.